Press Release

RNA Targeting Small Molecule Drug Discovery Market to Grow with a CAGR of 21.93% through 2030

The increasing prevalence of RNA-related diseases is expected to drive the growth of Global RNA Targeting Small Molecule Drug Discovery Market during the forecast period, 2026-2030.


According to TechSci Research report, “RNA Targeting Small Molecule Drug Discovery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2030” the Global RNA Targeting Small Molecule Drug Discovery market stood at USD 1.68 billion in 2024 and is anticipated to growth with a CAGR of 21.93% in the forecast period trough 2030. This can be ascribed to the growing demand for new drugs owing to the high burden of chronic and infectious diseases and the increased research and development costs. Additionally, the growing demand for generics and biosimilars are the major factors driving the growth of the market during the forecast period. Also, the growing demand for innovative and effective medicine will further boost the growth of the global RNA Targeting Small Molecule Drug Discovery market in the forecast period. Besides, governments around the world are providing support for the development of the healthcare industry, including funding for research and development, which is driving the demand for the Global RNA Targeting Small Molecule Drug Discovery Market during the forecast period. Similarly, growing research centers and biopharmaceuticals sectors are the major factors driving the growth of the market over the years.

However, small molecules can bind to multiple targets, including unintended targets, which can lead to unwanted side effects which can slow down the growth of the global RNA Targeting Small Molecule Drug Discovery market in the forecast period. Also, RNA-targeted small molecule drugs need to be delivered to the target cells and tissues to exert their therapeutic effects. Delivering small molecules to specific cells or tissues can be challenging, which may hamper the growth of the market during the forecast period. Similarly, RNA-targeted small molecule drugs face competition from other therapeutic modalities, including monoclonal antibodies, gene therapy, and RNA-based therapeutics which may restrict the growth of the market.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global RNA Targeting Small Molecule Drug Discovery Market.”


Global RNA Targeting Small Molecule Drug Discovery market can be segmented by Indication, End User, Region and Competitive Landscape.

Based on the Indication, Cancer category shows the fastest growth  during the forecast period. This can be ascribed to the growing prevalence of cancer diseases due to consuming alcohol and smoking along with growing research and development for developing new drugs. Also, the high prevalence of chronic diseases such as diabetes, HIV, and other diseases is further contributing to the demand for developing innovative therapies which will further drive the growth of the market during the forecast period.

Based on Region, ​The Asia Pacific region is emerging as a rapidly growing hub for RNA-targeting small molecule drug discovery. This growth is driven by several factors, including increasing investments in biotechnology, supportive government initiatives, and a rising prevalence of chronic diseases. Countries like China, India, and Japan are at the forefront, with expanding pharmaceutical industries and a growing focus on innovative therapeutic approaches. The region's large patient population and unmet medical needs further contribute to the demand for advanced RNA-targeted therapies. Collaborations between local and international biotech firms are also fostering innovation and accelerating the development of new treatments. As a result, Asia Pacific is becoming a significant player in the global RNA-targeting small molecule drug discovery landscape, offering promising opportunities for research and development.​


Major companies operating in the Global RNA Targeting Small Molecule Drug Discovery Market are:

  • Accent Therapeutics, Inc.
  • Anima Biotech Inc.
  • Arrakis Therapeutics, Inc.
  • AstraZeneca Plc
  • Epics Therapeutics, Inc.
  • Expansion Therapeutics, Inc.
  • F. Hoffmann-La Roche AG
  • H3 Biomedicine Inc.
  • PTC Therapeutics, Inc.
  • Ribometrix, Inc.


Download Free Sample Report

Customers can also request for 10% free customization on this report.


“North America was expected to dominate in the Global RNA Targeting Small Molecule Drug Discovery market due to the presence of many pharmaceutical and biotechnology companies in the region, as well as significant government funding for research and development in the life sciences. Similarly, the growing demand for RNA Targeting Small Molecule Drug Discovery , as these technologies are critical for developing new treatments and therapies along with the growing prevalence of chronic diseases such as cancer is expected to create lucrative growth in the market during the forecast period. Also, growing government funding for healthcare infrastructure and a large and rapidly expanding population is expected to drive the growth of the market during the forecast period. Furthermore, increased R&D spending in RNA molecule research and increased market demand for high-quality analytical equipment for RNA analysis will further create lucrative opportunities for market growth”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based global management consulting firm.

RNA Targeting Small Molecule Drug Discovery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases, Others), By End Users (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of global RNA Targeting Small Molecule Drug Discovery market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the Global RNA Targeting Small Molecule Drug Discovery market.


Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com

Relevant News